Article
Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity.
BMC cancer - 30 Apr 2014
Cortes-Dericks Lourdes, Froment Laurene, Boesch Ruben, Schmid Ralph Alexander, Karoubi Golnaz
Abstract excerpt
BACKGROUND: Conventional chemotherapy in malignant pleural mesothelioma (MPM) has minimal impact on patient survival due to the supposed chemoresistance of cancer stem cells (CSCs). We sought to identify a sub-population of chemoresistant cells by using putative CSC markers, aldehyde dehydrogenase (ALDH) and CD44 in three MPM cell lines; H28, H2052 and Meso4. METHODS: The Aldefluor assay was used to measure ALDH...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
